Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Smits

Showing results (191-200 of 220) with videos related to

Pageof 22
Sort By:
Nature Reviews. Clinical Oncology|March 24, 2022
Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Martin van den Bent, Matthias Preusser, et al.
Neuro-Oncology|July 2, 2020
Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastomaMartin van den Bent, Marica Eoli, Juan Manuel Sepulveda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2022
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC TrialKaspar Draaisma, C Mircea S Tesileanu, Iris de Heer, et al.
The Lancet. Oncology|January 5, 2024
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO groupNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Neuro-Oncology Advances|November 29, 2023
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohortKarin A van Garderen, Wies R Vallentgoed, Anna Lavrova, et al.
Magnetic Resonance in Medicine|January 25, 2023
Current state and guidance on arterial spin labeling perfusion MRI in clinical neuroimagingThomas Lindner, Divya S Bolar, Eric Achten, et al.
Neuro-Oncology|June 9, 2026
BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directionsKarisa C Schreck, Macarena I de la Fuente, Mary Jane Lim Fat, et al.
Neuro-Oncology|June 10, 2020
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomasJerrold L Boxerman, Chad C Quarles, Leland S Hu, et al.
Brain : a Journal of Neurology|February 4, 2012
The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansionsJavier Simón-Sánchez, Elise G P Dopper, Petra E Cohn-Hokke, et al.
Neuro-Oncology|August 8, 2015
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trialsBenjamin M Ellingson, Martin Bendszus, Jerrold Boxerman, et al.
Pageof 22

Showing results (191-200 of 220) with videos related to

Sort By:
Pageof 22
Nature Reviews. Clinical Oncology|March 24, 2022
Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Martin van den Bent, Matthias Preusser, et al.
Neuro-Oncology|July 2, 2020
Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastomaMartin van den Bent, Marica Eoli, Juan Manuel Sepulveda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2022
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC TrialKaspar Draaisma, C Mircea S Tesileanu, Iris de Heer, et al.
The Lancet. Oncology|January 5, 2024
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO groupNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Neuro-Oncology Advances|November 29, 2023
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohortKarin A van Garderen, Wies R Vallentgoed, Anna Lavrova, et al.
Magnetic Resonance in Medicine|January 25, 2023
Current state and guidance on arterial spin labeling perfusion MRI in clinical neuroimagingThomas Lindner, Divya S Bolar, Eric Achten, et al.
Neuro-Oncology|June 9, 2026
BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directionsKarisa C Schreck, Macarena I de la Fuente, Mary Jane Lim Fat, et al.
Neuro-Oncology|June 10, 2020
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomasJerrold L Boxerman, Chad C Quarles, Leland S Hu, et al.
Brain : a Journal of Neurology|February 4, 2012
The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansionsJavier Simón-Sánchez, Elise G P Dopper, Petra E Cohn-Hokke, et al.
Neuro-Oncology|August 8, 2015
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trialsBenjamin M Ellingson, Martin Bendszus, Jerrold Boxerman, et al.
Pageof 22